246 related articles for article (PubMed ID: 31140861)
1. The progresses in curcuminoids-based metal complexes: especially in cancer therapy.
Zhang Y; Khan AR; Fu M; Zhai Y; Yu A; Zhai G
Future Med Chem; 2019 May; 11(9):1035-1056. PubMed ID: 31140861
[TBL] [Abstract][Full Text] [Related]
2. Metal-containing drugs and novel coordination complexes in therapeutic anticancer applications--part II.
Kostova I
Anticancer Agents Med Chem; 2010 Jun; 10(5):352-3. PubMed ID: 20545617
[No Abstract] [Full Text] [Related]
3. Ruthenium Complexes: An Emerging Ground to the Development of Metallopharmaceuticals for Cancer Therapy.
Abid M; Shamsi F; Azam A
Mini Rev Med Chem; 2016; 16(10):772-86. PubMed ID: 26423699
[TBL] [Abstract][Full Text] [Related]
4. Diarylheptanoid: A privileged structure in drug discovery.
Sun DJ; Zhu LJ; Zhao YQ; Zhen YQ; Zhang L; Lin CC; Chen LX
Fitoterapia; 2020 Apr; 142():104490. PubMed ID: 32017968
[TBL] [Abstract][Full Text] [Related]
5. Editorial: Anticancer Ruthenium Complexes in Drug Discovery and Medicinal Chemistry.
Thota S
Mini Rev Med Chem; 2016; 16(10):771. PubMed ID: 27161007
[No Abstract] [Full Text] [Related]
6. Preface.
Prudhomme M
Anticancer Agents Med Chem; 2017; 17(1):3. PubMed ID: 28143384
[No Abstract] [Full Text] [Related]
7. Overview.
Prudhomme M
Anticancer Agents Med Chem; 2017; 17(1):2. PubMed ID: 28143383
[No Abstract] [Full Text] [Related]
8. Metal Complexes in Cancer Treatment: Journey So Far.
Kumar Singh A; Kumar A; Singh H; Sonawane P; Pathak P; Grishina M; Pal Yadav J; Verma A; Kumar P
Chem Biodivers; 2023 Apr; 20(4):e202300061. PubMed ID: 36824028
[TBL] [Abstract][Full Text] [Related]
9. Metal N-heterocyclic carbene complexes as potential antitumor metallodrugs.
Liu W; Gust R
Chem Soc Rev; 2013 Jan; 42(2):755-73. PubMed ID: 23147001
[TBL] [Abstract][Full Text] [Related]
10. Recent development of transition metal complexes with in vivo antitumor activity.
Liang JX; Zhong HJ; Yang G; Vellaisamy K; Ma DL; Leung CH
J Inorg Biochem; 2017 Dec; 177():276-286. PubMed ID: 28641893
[TBL] [Abstract][Full Text] [Related]
11. N-heterocyclic carbene metal complexes as bio-organometallic antimicrobial and anticancer drugs.
Patil SA; Patil SA; Patil R; Keri RS; Budagumpi S; Balakrishna GR; Tacke M
Future Med Chem; 2015; 7(10):1305-33. PubMed ID: 26144266
[TBL] [Abstract][Full Text] [Related]
12. Recent researches in metal supramolecular complexes as anticancer agents.
Zhou CH; Zhang YY; Yan CY; Wan K; Gan LL; Shi Y
Anticancer Agents Med Chem; 2010 Jun; 10(5):371-95. PubMed ID: 20380632
[TBL] [Abstract][Full Text] [Related]
13. Novel copper complexes as potential proteasome inhibitors for cancer treatment (Review).
Zhang Z; Wang H; Yan M; Wang H; Zhang C
Mol Med Rep; 2017 Jan; 15(1):3-11. PubMed ID: 27959411
[TBL] [Abstract][Full Text] [Related]
14. Diarylheptanoids with inhibitory effects on melanogenesis from the rhizomes of Curcuma comosa in B16 melanoma cells.
Matsumoto T; Nakamura S; Nakashima S; Yoshikawa M; Fujimoto K; Ohta T; Morita A; Yasui R; Kashiwazaki E; Matsuda H
Bioorg Med Chem Lett; 2013 Sep; 23(18):5178-81. PubMed ID: 23910596
[TBL] [Abstract][Full Text] [Related]
15. Development of Arene Ruthenium Antitumor Complexes.
Su W; Tang Z; Li P
Mini Rev Med Chem; 2016; 16(10):787-95. PubMed ID: 27161008
[TBL] [Abstract][Full Text] [Related]
16. Platinum, palladium, gold and ruthenium complexes as anticancer agents: Current clinical uses, cytotoxicity studies and future perspectives.
Lazarević T; Rilak A; Bugarčić ŽD
Eur J Med Chem; 2017 Dec; 142():8-31. PubMed ID: 28442170
[TBL] [Abstract][Full Text] [Related]
17. Progresses in TCM metal-based antitumour agents.
Chen ZF; Liang H
Anticancer Agents Med Chem; 2010 Jun; 10(5):412-23. PubMed ID: 20545619
[TBL] [Abstract][Full Text] [Related]
18. Curcuminoids from
Cunha Neto F; Marton LT; de Marqui SV; Lima TA; Barbalho SM
Crit Rev Food Sci Nutr; 2019; 59(13):2136-2143. PubMed ID: 29565637
[TBL] [Abstract][Full Text] [Related]
19. The Next Generation of Anticancer Metallopharmaceuticals: Cancer Stem Cell-Active Inorganics.
Laws K; Suntharalingam K
Chembiochem; 2018 Nov; 19(21):2246-2253. PubMed ID: 30109911
[TBL] [Abstract][Full Text] [Related]
20. Tracking antitumor metallodrugs: promising agents with the Ru(II)- and Fe(II)-cyclopentadienyl scaffolds.
Morais TS; Valente A; Tomaz AI; Marques F; Garcia MH
Future Med Chem; 2016 Apr; 8(5):527-44. PubMed ID: 27096164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
